ReviewAging2026
Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions.
Review in Aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For decades, research on cellular senescence has predominantly focused on the static identification of senescent cells using markers such as p16 and β-galactosidase, largely overlooking their functional heterogeneity across spatiotemporal dimensions. Accumulating evidence reveals that senescent cells are not merely deleterious pathological byproducts; rather, a subset plays indispensable physiological roles in embryonic development, wound healing, and the maintenance of tissue homeostasis. Based on these insights, this review summarizes the induction mechanisms of cellular senescence and the subsequent evolution of their functional phenotypes across diverse tissues. Consequently, we propose a novel paradigm for senescence management centered on "prevention first, followed by precision intervention." This strategy involves, on one hand, mitigating environmental stressors and optimizing metabolism to intercept the onset of detrimental senescence at its source. On the other hand, it advocates for the functional profiling of existing senescent populations via single-cell omics and lineage tracing, enabling the targeted clearance of "maladaptive" components that drive pathological phenotypes while preserving "beneficial" elements essential for physiological stability. Such a systematic intervention, grounded in the classification of induction factors and functional subtypes, offers a safer and more efficacious trajectory for the prevention of age-related diseases and the extension of healthspan.
Indexed as
Identifiers
42095817What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.